Bioextrax AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 0.032 million compared to SEK 0.183 million a year ago. Revenue was SEK 0.827 million compared to SEK 0.636 million a year ago. Net loss was SEK 5.79 million compared to SEK 2.9 million a year ago. Basic loss per share from continuing operations was SEK 0.26. Diluted loss per share from continuing operations was SEK 0.26.
For the full year, sales was SEK 0.395 million compared to SEK 0.276 million a year ago. Revenue was SEK 2.23 million compared to SEK 1.03 million a year ago. Net loss was SEK 18.67 million compared to SEK 10.53 million a year ago. Basic loss per share from continuing operations was SEK 1.1. Diluted loss per share from continuing operations was SEK 1.1.